Mifepristone demonstrated safety, efficacy in Cushing--™s syndrome trials
Links shared publicly online about this topic.
- 581total visits
Mifepristone demonstrated safety, efficacy in Cushing--™s syndrome trials
Phase 3 study data indicate that mifepristone alleviated hypertension, improved glucose intolerance and was well tolerated by patients with Cush
View full resource at endocrinetoday.com
Tags: Heart Disease, High Blood Pressure, Disease and Condition, Phase 3 Clinical Trial, Suction-Aspiration Abortion, Mifeprex, RU-486, Safety
Most Recently Shared on January 14, 2011 at 10:11 pm By:
RT @endocrinetoday: #Mifepristone demonstrated safety, efficacy in #Cushing’s syndrome trials http://bit.ly/gVp1fG
Also Shared By:
Advertisement
Endocrine Today
@EndocrineToday
#Mifepristone demonstrated safety, efficacy in #Cushing’s syndrome trials http://bit.ly/gVp1fG
1 year ago...